Conditions: Osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 207
Healthy volunteers: no

Brief summary:
To evaluate the efficacy of teriparatide based on measurements of bone mineral density at lumbar spine

Detailed description:

Arms:
arm 1: 20 micrograms for 104 weeks arm 2: Placebo for 52 weeks. After 52 weeks, all patients on placebo can receive 20 micrograms teriparatide for 52 weeks

Interventions: intervention 1: Teriparatide intervention 2: Placebo
Intervention descriptions: intervention 1: daily, subcutaneous intervention 2: daily, subcutaneous

Protocol document: